A Study of the Epidemiology and Hospital Management of Patients With PROS in France

Clinical trial NCT07222423 · COMPLETED

Trial details

NCT number: NCT07222423
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

PIK3CA-Related Overgrowth Spectrum

Start date: 2024-01-15
Primary completion: 2024-10-08
Enrollment: 3605

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.